Get Your Personalized Supplement StackSupplement Stack Quiz

Menaq7 Vitamin K2

Also known as: Vitamin K2, Menaquinone, MK-7, MenaQ7, MenaQ7 (Vitamin K2 MK-7)

Overview

MenaQ7 is a brand of vitamin K2, specifically the MK-7 form, which is crucial for activating proteins related to bone mineralization and vascular health. This form of vitamin K2 is more efficacious than vitamin K1 due to its superior bioavailability and longer half-life, making it a preferred choice in supplementation. The primary sources of vitamin K2 MK-7 include fermented foods, particularly natto, which is a traditional Japanese dish. Research indicates that vitamin K2 supplementation may significantly enhance bone mineral density and promote cardiovascular health, although findings regarding cardiovascular effects have been mixed. Overall, MenaQ7 plays a vital role in maintaining bone health and potentially influencing cardiovascular functionality.

Benefits

The most significant evidence supports vitamin K2 MK-7's positive impact on bone health, specifically in postmenopausal women. A systematic review and meta-analysis of 16 randomized controlled trials showed that supplementation led to a significant improvement in lumbar spine bone mineral density (BMD) with a p-value of 0.006. Furthermore, the risk of fractures was reduced (RR = 0.43, p = 0.01) when one heterogeneous study was excluded. Regarding cardiovascular health, some studies indicated improved arterial stiffness following MK-7 supplementation, but results concerning vascular calcification remain inconclusive, with one study showing no impact on calcification in patients with type 2 diabetes. Overall, while bone health benefits are strong, cardiovascular effects warrant further investigation.

How it works

Vitamin K2 MK-7 activates proteins that regulate calcium metabolism, crucial for bone mineralization and cardiovascular health. It facilitates the synthesis of osteocalcin, a protein that binds calcium to the bone, promoting stronger bone density. Additionally, vitamin K2 prevents arterial calcification by activating Matrix Gla-Protein (MGP), which inhibits vascular calcification, thereby supporting cardiovascular function.

Side effects

Vitamin K2 is generally regarded as safe with minimal reported adverse effects. In meta-analyses, no significant differences in adverse reactions between vitamin K2 and control groups were observed (RR = 1.03, p = 0.76). However, potential interactions exist with anticoagulants, which may exacerbate bleeding risks. A case report has indicated mild hypotension possibly linked to vitamin K2 supplementation. Therefore, individuals on such medications should consult healthcare providers prior to use. While adverse effects are rare, monitoring for any unusual symptoms during supplementation is prudent.

Dosage

The typical recommended dosage of MenaQ7 vitamin K2 MK-7 ranges from 180 to 360 micrograms per day, particularly for supporting bone health. For optimal absorption, it is advised to take vitamin K2 with meals containing fats, given its fat-soluble nature. Specific populations, such as postmenopausal women, may benefit most from the higher end of this dosage range. Upper safety limits for long-term supplementation are not well-established, making further research necessary to determine threshold levels beyond which adverse effects may arise.

FAQs

Is MenaQ7 safe to take with medications?

While MenaQ7 is generally safe, it can interact with anticoagulants, so it's crucial to consult a healthcare provider before starting supplementation.

What are the main benefits of MenaQ7?

MenaQ7 primarily aids in improving bone mineral density and may help reduce fracture risk, particularly in postmenopausal women.

How does MenaQ7 compare to other forms of vitamin K?

MenaQ7 (MK-7) has a longer half-life and higher bioavailability than other forms like K1, making it more effective for activating vitamin K-dependent proteins.

What should I monitor while taking MenaQ7?

Monitor for any unusual symptoms or side effects, especially if on anticoagulant therapy; regular check-ups with a healthcare provider are recommended.

Research Sources

https://pubmed.ncbi.nlm.nih.gov/36033779/ – This meta-analysis reviewed multiple RCTs and concluded that vitamin K2 supplementation significantly improves lumbar spine bone mineral density and reduces the incidence of fractures among postmenopausal women.
https://pubmed.ncbi.nlm.nih.gov/23590754/ – This study assessed the effect of MK-7 on arterial stiffness and, while improvements were noted, it highlighted inconsistencies with other cardiovascular markers and emphasized further research is needed.
https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Vitamin-K2.pdf – The document discusses the safety profile of vitamin K2, concluding no significant adverse reactions were linked to its supplementation across various clinical trials, reinforcing its general safety.
https://ods.od.nih.gov/factsheets/VitaminK-HealthProfessional/ – This fact sheet provides comprehensive information on vitamin K, including its different forms, dietary sources, and its vital role in bone and cardiovascular health, alongside safety notes.
https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.979649/full – This article offers an overview of the health benefits of vitamin K2, discussing its evidence of enhancing bone health while outlining some mixed findings regarding cardiovascular impacts.